These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 27893001)

  • 1. Association of Improved Locoregional Control With Prolonged Survival in Early-Stage Extranodal Nasal-Type Natural Killer/T-Cell Lymphoma.
    Yang Y; Cao JZ; Lan SM; Wu JX; Wu T; Zhu SY; Qian LT; Hou XR; Zhang FQ; Zhang YJ; Zhu Y; Xu LM; Yuan ZY; Qi SN; Li YX
    JAMA Oncol; 2017 Jan; 3(1):83-91. PubMed ID: 27893001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiotherapy is essential after complete response to asparaginase-containing chemotherapy in early-stage extranodal nasal-type NK/T-cell lymphoma: A multicenter study from the China Lymphoma Collaborative Group (CLCG).
    Deng XW; Wu JX; Wu T; Zhu SY; Shi M; Su H; Wang Y; He X; Xu LM; Yuan ZY; Zhang LL; Wu G; Qu BL; Qian LT; Hou XR; Zhang FQ; Zhang YJ; Zhu Y; Cao JZ; Lan SM; Dong M; Qi SN; Yang Y; Li YX
    Radiother Oncol; 2018 Oct; 129(1):3-9. PubMed ID: 29739712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Outcome of radiotherapy for low-risk early-stage patients with extranodal NK/T-cell lymphoma, nasal-type].
    Wang XD; Liu X; Wu T; Yang Y; Qi SN; He X; Zhang LL; Wu G; Qu BL; Qian LT; Hou XR; Zhang FQ; Qiao XY; Wang H; Li GF; Zhu Y; Cao JZ; Wu JX; Zhu SY; Shi M; Su H; Zhang XM; Zhang HL; Huang HQ; Zhang YJ; Song YQ; Zhu J; Wang Y; Li YX
    Zhonghua Zhong Liu Za Zhi; 2021 Oct; 43(10):1105-1113. PubMed ID: 34695903
    [No Abstract]   [Full Text] [Related]  

  • 4. [Long-term effect of risk-adaptive therapy for early stage extranodal NK/T cell lymphoma].
    Wu T; Liu QL; Hu YF; Zhang J; Chen MX; Chen XX; Huang YH; Lu B
    Zhonghua Zhong Liu Za Zhi; 2019 Nov; 41(11):859-864. PubMed ID: 31770855
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment outcomes of and prognostic factors for definitive radiotherapy with and without chemotherapy for Stage I/II nasal extranodal NK/T-cell lymphoma.
    Yang CW; Wang CW; Hong RL; Tsai CL; Yao M; Tang JL; Lin CW; Cheng AL; Kuo SH
    J Radiat Res; 2017 Jan; 58(1):114-122. PubMed ID: 27534792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early radiotherapy has an essential role for improving survival in patients with stage I-II nasal-type of NK/T cell lymphoma treated with L-asparaginase-containing chemotherapy--a single institution experience.
    Zang J; Li C; Luo SQ; Wang JH; Xu M; Zhao LN; Li WW; Yang H; Xiao F; Hitchcock YJ; Shi M
    Ann Hematol; 2015 Apr; 94(4):583-91. PubMed ID: 25409913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of the omission or inadequate dosing of radiotherapy in extranodal natural killer T-cell lymphoma, nasal type, in the United States.
    Vargo JA; Patel A; Glaser SM; Balasubramani GK; Farah RJ; Marks SM; Beriwal S
    Cancer; 2017 Aug; 123(16):3176-3185. PubMed ID: 28380259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early or up-front radiotherapy improved survival of localized extranodal NK/T-cell lymphoma, nasal-type in the upper aerodigestive tract.
    Huang MJ; Jiang Y; Liu WP; Li ZP; Li M; Zhou L; Xu Y; Yu CH; Li Q; Peng F; Liu JY; Luo F; Lu Y
    Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):166-74. PubMed ID: 17919841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose and extended-field intensity modulated radiation therapy for early-stage NK/T-cell lymphoma of Waldeyer's ring: dosimetric analysis and clinical outcome.
    Bi XW; Li YX; Fang H; Jin J; Wang WH; Wang SL; Liu YP; Song YW; Ren H; Dai JR
    Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1086-93. PubMed ID: 24120822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of gross tumor volume and radiation dose on survival and locoregional recurrence in early-stage extranodal NK/T-cell lymphoma treated with intensity-modulated radiation therapy.
    Zhou YM; Liu X; Yang Y; Wang SL; Fang H; Song YW; Liu YP; Jin J; Li N; Lu NN; Jing H; Tang Y; Chen B; Zhang WW; Zhai YR; Men K; Dai JR; Deng M; Qi SN; Li YX
    J Cancer Res Clin Oncol; 2023 Jul; 149(8):5219-5230. PubMed ID: 36374333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined chemoradiation for the management of nasal natural killer (NK)/T-cell lymphoma: elucidating the significance of systemic chemotherapy.
    Guo Y; Lu JJ; Ma X; Wang B; Hong X; Li X; Li J
    Oral Oncol; 2008 Jan; 44(1):23-30. PubMed ID: 17306611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk-dependent curability of radiotherapy for elderly patients with early-stage extranodal nasal-type NK/T-cell lymphoma: A multicenter study from the China Lymphoma Collaborative Group (CLCG).
    Chen B; Zhu SY; Shi M; Su H; Wang Y; He X; Xu LM; Yuan ZY; Zhang LL; Wu G; Qu BL; Qian LT; Hou XR; Zhang FQ; Zhang YJ; Zhu Y; Cao JZ; Lan SM; Wu JX; Wu T; Qi SN; Yang Y; Liu X; Li YX
    Cancer Med; 2018 Dec; 7(12):5952-5961. PubMed ID: 30358175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
    Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary radiotherapy showed favorable outcome in treating extranodal nasal-type NK/T-cell lymphoma in children and adolescents.
    Wang ZY; Li YX; Wang WH; Jin J; Wang H; Song YW; Liu QF; Wang SL; Liu YP; Qi SN; Fang H; Liu XF; Yu ZH
    Blood; 2009 Nov; 114(23):4771-6. PubMed ID: 19812381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Roles of Radiotherapy and Chemotherapy in the Era of Multimodal Treatment for Early-Stage Nasal-Type Extranodal Natural Killer/T-Cell Lymphoma.
    Kim TH; Kim JS; Suh YG; Cho J; Yang WI; Suh CO
    Yonsei Med J; 2016 Jul; 57(4):846-54. PubMed ID: 27189276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk-adapted therapy for early-stage extranodal nasal-type NK/T-cell lymphoma: analysis from a multicenter study.
    Yang Y; Zhu Y; Cao JZ; Zhang YJ; Xu LM; Yuan ZY; Wu JX; Wang W; Wu T; Lu B; Zhu SY; Qian LT; Zhang FQ; Hou XR; Li YX
    Blood; 2015 Sep; 126(12):1424-32; quiz 1517. PubMed ID: 26109206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical disparity and favorable prognoses for patients with Waldeyer ring extranodal nasal-type NK/T-cell lymphoma and diffuse large B-cell lymphoma.
    Wu RY; Li YX; Wang WH; Jin J; Wang SL; Liu YP; Song YW; Fang H; Ren H; Liu QF; Wang ZY; Qi SN; Lu NN; Chen B; Zhang XM; Zhou LQ; Liu XF; Yu ZH
    Am J Clin Oncol; 2014 Feb; 37(1):41-6. PubMed ID: 22992625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
    Zou GR; Zhang YJ; Xie FY; Zheng W; Li HX; Xia YF; Lin TY; Lu TX
    Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequential chemotherapy/radiotherapy was comparable with concurrent chemoradiotherapy for stage I/II NK/T-cell lymphoma.
    Kwong YL; Kim SJ; Tse E; Oh SY; Kwak JY; Eom HS; Do YR; Mun YC; Lee SR; Shin HJ; Suh C; Chuang SS; Lee YS; Lim ST; Izutsu K; Suzuki R; Relander T; d'Amore F; Schmitz N; Jaccard A; Kim WS
    Ann Oncol; 2018 Jan; 29(1):256-263. PubMed ID: 29077846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment and Prognosis of Newly Diagnosed Advanced-Stage Extranodal Natural Killer/T-Cell Lymphoma: A Single-Center Real-World Study across Two Decades.
    Wei YC; Qi F; Chen B; Zhang CG; Fang H; Zhang D; Qi SN; Chai Y; Li YX; Dong M
    Chemotherapy; 2024; 69(2):108-121. PubMed ID: 37984344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.